These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1922389)

  • 1. On the development of alternative antiepileptic drugs. Lack of enantioselectivity of the anticonvulsant activity, in contrast to teratogenicity, of 2-n-propyl-4-pentenoic acid and 2-n-propyl-4-pentynoic acid, analogues of the anticonvulsant drug valproic acid.
    Hauck RS; Nau H; Elmazar MM
    Naturwissenschaften; 1991 Jun; 78(6):272-4. PubMed ID: 1922389
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
    Löscher W; Nau H; Marescaux C; Vergnes M
    Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid.
    Elmazar MM; Hauck RS; Nau H
    J Pharm Sci; 1993 Dec; 82(12):1255-8. PubMed ID: 8308706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we develop improved derivatives of valproic acid?
    Bialer M; Haj-Yehia A; Badir K; Hadad S
    Pharm World Sci; 1994 Feb; 16(1):2-6. PubMed ID: 8156045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of amino analogues of valproic acid.
    Scott KR; Adesioye S; Ayuk PB; Edafiogho IO; John D; Kodwin P; Maxwell-Irving T; Moore JA; Nicholson JM
    Pharm Res; 1994 Apr; 11(4):571-4. PubMed ID: 8058618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA; Yagen B; Pessah N; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice.
    Nau H; Löscher W
    Fundam Appl Toxicol; 1986 May; 6(4):669-76. PubMed ID: 3086174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.
    Shimshoni JA; Yagen B; Wlodarczyk B; Finnell RH; Schurig V; Bialer M
    Epilepsia; 2010 Mar; 51(3):323-32. PubMed ID: 19674061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of unsaturated analogues of valproic acid.
    Palaty J; Abbott FS
    J Med Chem; 1995 Aug; 38(17):3398-406. PubMed ID: 7650693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
    Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
    Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic Activity of a New Derivative of Benzimidazole RU-1205.
    Spasov AA; Kalitin KY; Grechko OY; Anisimova VA
    Bull Exp Biol Med; 2016 Jan; 160(3):336-9. PubMed ID: 26742743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid.
    Hauck RS; Nau H
    Toxicol Lett; 1989 Oct; 49(1):41-8. PubMed ID: 2510370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
    Andrews JE; Ebron-McCoy MT; Bojic U; Nau H; Kavlock RJ
    Teratology; 1997 May; 55(5):314-8. PubMed ID: 9261925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
    Nau H
    Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
    Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
    Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice.
    Keane PE; Simiand J; Mendes E; Santucci V; Morre M
    Neuropharmacology; 1983 Jul; 22(7):875-9. PubMed ID: 6413882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.